![Stefan Brugger](https://profiles-cardiff.imgix.net/attachments/7630?w=200&h=200&auto=format&crop=faces&fit=crop&q=90")
Publication
2024
- Harding, J. N. et al., 2024. A new predictive coding model for a more comprehensive account of delusions. The Lancet Psychiatry 11 (4), pp.295-302. (10.1016/S2215-0366(23)00411-X)
- Harding, J. N. et al., 2024. Predictive coding and phenomenological approaches of delusions: convergence and differences ? Authors' reply. The Lancet Psychiatry 11 (7) 498. (10.1016/S2215-0366(24)00141-X)
2023
- McCutcheon, R. A. et al., 2023. Shared and separate patterns in brain morphometry across transdiagnostic dimensions. nature mental health 1 , pp.55-65. (10.1038/s44220-022-00010-y)
2022
- Beck, K. et al., 2022. The association between N-methyl-d-aspartate receptor availability and glutamate levels: A multi-modal PET-MR brain imaging study in first-episode psychosis and healthy controls. Journal of Psychopharmacology 36 (9), pp.1051-1060. (10.1177/02698811221099643)
- Osimo, E. F. et al., 2022. A cross-sectional MR study of body fat volumes and distribution in chronic schizophrenia. npj Schizophrenia 8 (1) 24. (10.1038/s41537-022-00233-z)
- Rajpal, H. et al., 2022. Psychedelics and schizophrenia: Distinct alterations to Bayesian inference. NeuroImage 263 119624. (10.1016/j.neuroimage.2022.119624)
2021
- Angelescu, I. et al., 2021. The magnitude and variability of brain structural alterations in bipolar disorder: A double meta-analysis of 5534 patients and 6651 healthy controls. Journal of Affective Disorders 291 , pp.171-176. (10.1016/j.jad.2021.04.090)
2020
- Brugger, S. P. et al. 2020. Heterogeneity of striatal dopamine function in schizophrenia: meta-analysis of variance. Biological Psychiatry 87 (3), pp.215-224. (10.1016/j.biopsych.2019.07.008)
- Mizuno, Y. et al., 2020. Heterogeneity and efficacy of antipsychotic treatment for schizophrenia with or without treatment resistance: a meta-analysis. Neuropsychopharmacology 45 (4), pp.622-631. (10.1038/s41386-019-0577-3)
2018
- Howes, O. et al., 2018. Brain structural and neurochemical heterogeneity and homogeneity in psychotic disorders: transdiagnostic pet and mri imaging findings in schizophrenia and bipolar affective disorder. Schizophrenia Bulletin 44 , pp.S13. (10.1093/schbul/sby014.030)
2013
- Carhart-Harris, R. et al., 2013. Psychiatry's next top model: cause for a re-think on drug models of psychosis and other psychiatric disorders. Journal of Psychopharmacology 27 (9), pp.771-778. (10.1177/0269881113494107)
2012
- Egerton, A. et al., 2012. Anterior cingulate glutamate levels related to clinical status following treatment in first-episode schizophrenia. Neuropsychopharmacology 37 (11), pp.2515-2521. (10.1038/npp.2012.113)
2011
- Brugger, S. et al. 2011. Proton magnetic resonance spectroscopy and illness stage in schizophrenia-a systematic review and meta-analysis. Biological Psychiatry 69 (5), pp.495-503. (10.1016/j.biopsych.2010.10.004)
Articles
- Angelescu, I. et al., 2021. The magnitude and variability of brain structural alterations in bipolar disorder: A double meta-analysis of 5534 patients and 6651 healthy controls. Journal of Affective Disorders 291 , pp.171-176. (10.1016/j.jad.2021.04.090)
- Beck, K. et al., 2022. The association between N-methyl-d-aspartate receptor availability and glutamate levels: A multi-modal PET-MR brain imaging study in first-episode psychosis and healthy controls. Journal of Psychopharmacology 36 (9), pp.1051-1060. (10.1177/02698811221099643)
- Brugger, S. et al. 2011. Proton magnetic resonance spectroscopy and illness stage in schizophrenia-a systematic review and meta-analysis. Biological Psychiatry 69 (5), pp.495-503. (10.1016/j.biopsych.2010.10.004)
- Brugger, S. P. et al. 2020. Heterogeneity of striatal dopamine function in schizophrenia: meta-analysis of variance. Biological Psychiatry 87 (3), pp.215-224. (10.1016/j.biopsych.2019.07.008)
- Carhart-Harris, R. et al., 2013. Psychiatry's next top model: cause for a re-think on drug models of psychosis and other psychiatric disorders. Journal of Psychopharmacology 27 (9), pp.771-778. (10.1177/0269881113494107)
- Egerton, A. et al., 2012. Anterior cingulate glutamate levels related to clinical status following treatment in first-episode schizophrenia. Neuropsychopharmacology 37 (11), pp.2515-2521. (10.1038/npp.2012.113)
- Harding, J. N. et al., 2024. A new predictive coding model for a more comprehensive account of delusions. The Lancet Psychiatry 11 (4), pp.295-302. (10.1016/S2215-0366(23)00411-X)
- Harding, J. N. et al., 2024. Predictive coding and phenomenological approaches of delusions: convergence and differences ? Authors' reply. The Lancet Psychiatry 11 (7) 498. (10.1016/S2215-0366(24)00141-X)
- Howes, O. et al., 2018. Brain structural and neurochemical heterogeneity and homogeneity in psychotic disorders: transdiagnostic pet and mri imaging findings in schizophrenia and bipolar affective disorder. Schizophrenia Bulletin 44 , pp.S13. (10.1093/schbul/sby014.030)
- McCutcheon, R. A. et al., 2023. Shared and separate patterns in brain morphometry across transdiagnostic dimensions. nature mental health 1 , pp.55-65. (10.1038/s44220-022-00010-y)
- Mizuno, Y. et al., 2020. Heterogeneity and efficacy of antipsychotic treatment for schizophrenia with or without treatment resistance: a meta-analysis. Neuropsychopharmacology 45 (4), pp.622-631. (10.1038/s41386-019-0577-3)
- Osimo, E. F. et al., 2022. A cross-sectional MR study of body fat volumes and distribution in chronic schizophrenia. npj Schizophrenia 8 (1) 24. (10.1038/s41537-022-00233-z)
- Rajpal, H. et al., 2022. Psychedelics and schizophrenia: Distinct alterations to Bayesian inference. NeuroImage 263 119624. (10.1016/j.neuroimage.2022.119624)
